University of Maryland Center for Environmental Science

Simulations Plus Receives New FDA Grant Award

Retrieved on: 
Thursday, September 21, 2023
Science, Other Science, Biotechnology, Research, Pharmaceutical, Health, FDA, Health Technology, United States Department of Health and Human Services, Associate Director of National Intelligence and Chief Information Officer, University, SLP, Human services, Independent agencies of the United States government, Simulations Plus, History, Government, Name, Food and Drug Administration, Patient, VBE, University of Maryland Center for Environmental Science, Principal, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Food, Medical device

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced it has been awarded a new funded grant from the U.S. Food and Drug Administration (FDA).

Key Points: 
  • Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced it has been awarded a new funded grant from the U.S. Food and Drug Administration (FDA).
  • The grant will be used to validate and define best practices for physiologically based biopharmaceutics/pharmacokinetics (PBBM/PBPK) modeling workflows to simulate virtual bioequivalence (VBE) studies in support of regulatory biowaivers.
  • The scientific team at Simulations Plus, with partners from the FDA, industry, and academia, will apply public and proprietary datasets to validate the ability of GastroPlus® and other software to predict inter- and intra-subject variability when performing virtual population simulations.
  • Dr. Martins, with assistance from Simulations Plus colleagues Dr. Maxime Le Merdy , Dr. Géraldine Cellière , and Mr. James Mullin , will coordinate all activities of the award.

BIONIC Continues Work to Minimize Impacts from Misinformation and Disinformation

Retrieved on: 
Tuesday, June 27, 2023
Exercise, Intelligence, Learning, Chaminade University of Honolulu, Small business, Partnership, Searching, Police Technology Department, Health, TTP/A, U.S. Department of Defense Strategy for Operating in Cyberspace, R & D, HBCU, United States Intelligence Community, University, Research, Mentorship, Element, Bowie State University, Unified combatant command, National Cybersecurity FFRDC, Student, Trust, BSU, Machine learning, Local government, CMI, University of Maryland Center for Environmental Science, Climate, AI, R, Vaccine, Management, Pacific Ocean, MD

Bowie State’s Influence Operations National Innovation Center (BIONIC) was introduced last year as a national public-private partnership consortium consisting of only academia and small businesses.

Key Points: 
  • Bowie State’s Influence Operations National Innovation Center (BIONIC) was introduced last year as a national public-private partnership consortium consisting of only academia and small businesses.
  • “Our students are gaining invaluable experience by conducting research for the BIONIC initiative and contributing to enhancing the nation’s capability to minimize misinformation and disinformation that impacts everyone,” said Dr. Lethia Jackson, chair of BSU’s Security and Technology Department.
  • BIONIC is designed to integrate students, academia and industry expertise and capabilities for dual-use approaches to combat digital malign activity, addressing both national security and U.S. citizen consequences arising from adversarial misinformation, disinformation, and influence operations.
  • “As a key academic partner with BIONIC, we are educating our students on how misinformation and disinformation in areas such as healthcare, climate and economic justice affect them, their families and communities.

UMD Smith to Launch Enterprise Risk Consortium

Retrieved on: 
Thursday, June 1, 2023
Group Policy, University of Maryland School of Public Policy, University, Education, Fannie Mae, Capitol Hill, Instability, Executive education, Business, Risk management, Risk assessment, Smith School, Research, Doctor of Philosophy, Government, Robert H. Smith School of Business, Organization, Student, Food and Drug Administration Amendments Act of 2007, Climate change, Congress, Risk, Citigroup, Freddie Mac, University of Maryland Center for Environmental Science, Knowledge, Climate, Weather, Policy, UMD, Environment, Food, GSE, Management, Arthur Longbrake

The school, through its Office of Executive Education , will launch a Smith Enterprise Risk Consortium during summer 2023 to provide industry-leading insights, applied research and risk analytics, risk management training programs, special events and a paid membership level for customized access to experts and training.

Key Points: 
  • The school, through its Office of Executive Education , will launch a Smith Enterprise Risk Consortium during summer 2023 to provide industry-leading insights, applied research and risk analytics, risk management training programs, special events and a paid membership level for customized access to experts and training.
  • The consortium will position Smith "as an academic leader in applied risk management through thought leadership, education and outreach to industry and governmental organizations, and by formalizing industry ties to Smith students interested in careers in risk management," says Clifford Rossi , PhD, professor of the practice and executive-in-residence for the Smith School.
  • "A community of practitioners with a vested interest in advancing the field of risk management will drive this initiative," says Koenick.
  • With such insight, the Smith School has "a prominent track record in risk management through leading media outlets and as a trusted advisor to corporations, agencies and legislators in risk management," says Smith Dean Prabhudev Konana .

Vaxcyte Expands Executive Leadership Team with Key Appointments

Retrieved on: 
Tuesday, October 11, 2022
SAN, Hepatitis A, Drug, Infection, Private Securities Litigation Reform Act, Licensure, Corporation, University, National, Chemistry, Antigen, Rituximab, Pfizer, Vaccine, Johnson & Johnson, TRACON, Genentech, Executive, Company, Marketing, GLOBE, Genetically modified bacteria, Harbor–UCLA Medical Center, History of the University of Maryland, College Park, Sutro Biopharma, Shigella, Biogen, University of Maryland Center for Environmental Science, Security (finance), U.S. Securities and Exchange Commission, PCV, Syracuse University, Ebola, Measles, SEC, Business, Periodontal disease, Schering-Plough, Business development, Public health, Management, Pharmaceutical industry, Merck, Medicine, Growth, COVID-19, Epidemiology

SAN CARLOS, Calif., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today announced the appointment of Mark Wiggins as Chief Business Officer and Jakub Simon as Chief Medical Officer. Both Mark and Jakub are accomplished industry leaders who bring vast expertise that will support the continued growth and advancement of the Company.

Key Points: 
  • Vaxcyte is poised for substantial growth with a potential global PCV vaccine franchise, said Mark Wiggins, Chief Business Officer of Vaxcyte.
  • Im thrilled to be joining the Company at this stage and to be part of a dedicated, forward-thinking team on a mission to advance such important vaccines.
  • I am pleased to join this team driven by a bold mission grounded in addressing significant public health challenges with respect to bacterial infectious diseases and antibiotic resistance, said Jakub Simon, Chief Medical Officer of Vaxcyte.
  • Vaxcyte is driven to eradicate or treat invasive bacterial infections, which have serious and costly health consequences when left unchecked.

WishBone Medical Appoints Dr. John E. Herzenberg to Board of Directors

Retrieved on: 
Wednesday, October 5, 2022
University of Maryland Rehabilitation & Orthopaedic Institute, Marketing, Orthopedic surgery, Hospital, Infection, Patient, U.S. News & World Report, University of Maryland Center for Environmental Science, Surgeon, Innovation, University, MD, CEO, International Center, Faculty, Sinai Hospital, Marketing communications, News, GLOBE, Boston University, Ponseti method, Elective surgery, Efficiency, FRCSC, Communication, CAT, Solution, History of the University of Maryland, College Park, Duke University, Medicine, Dentistry, USSR

WARSAW, Ind., Oct. 05, 2022 (GLOBE NEWSWIRE) -- WishBone Medical, Inc., a leader in pediatric orthopedic medical devices, is pleased to announce the appointment of John Herzenberg, MD, FRCSC, FAAOS, to its board of directors.

Key Points: 
  • WARSAW, Ind., Oct. 05, 2022 (GLOBE NEWSWIRE) -- WishBone Medical, Inc., a leader in pediatric orthopedic medical devices, is pleased to announce the appointment of John Herzenberg, MD, FRCSC, FAAOS, to its board of directors.
  • Dr. Herzenbergs clinical expertise coupled with his commitment to product innovation makes him a strong asset to our board, says Nick Deeter, Founder, Chairman, and CEO of WishBone Medical.
  • After medical school at Boston University, Herzenberg completed his residency in orthopedic surgery at Duke University and subspecialty training in pediatric orthopedics at the Hospital for Sick Children in Toronto.
  • Dr. Herzenberg co-founded the Maryland Center for Limb Lengthening & Reconstruction at Kernan Hospital.

Orgenesis Achieves Revenue of $7.2 Million for the Second Quarter of 2022

Retrieved on: 
Tuesday, August 16, 2022
Telephone, Metalmark, Energy Independence and Security Act of 2007, RISK, U.S. Securities and Exchange Commission, Cell, Industry, CEO, GLOBE, Technology, Growth, Regenerative medicine, Hospital, Protest and strikes of the CGT union 2021, Potency (pharmacology), Research, Annual report, Security (finance), Government, Patient, 8-K, Therapy, COVID-19, Company, Contract, NASDAQ, University of Maryland Center for Environmental Science, Â, An Act to exempt a particular class of securities from the Securities and Exchange Act, Johns Hopkins, Securities Act of 1933, JV, Diabetes, Metalmark Capital, CGT, Conference, Pharmaceutical industry, Online shopping, Fausto Pocar, Labs

GERMANTOWN, Md., Aug. 16, 2022 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies (CGT), today provided a business update for second quarter ending June 30, 2022.

Key Points: 
  • Orgenesis to Host Conference Call Today, August 16, 2022 at 11 AM Eastern Time
    GERMANTOWN, Md., Aug. 16, 2022 (GLOBE NEWSWIRE) -- Orgenesis Inc .
  • (NASDAQ: ORGS) (Orgenesis or the Company), a global biotech company working to unlock the full potential of cell and gene therapies (CGT), today provided a business update for second quarter ending June 30, 2022.
  • Vered Caplan, CEO of Orgenesis, said, We are progressing with our transition to the second phase of the planned rollout of our POCare platform.
  • This includes revenue generation from the validation, process development, and supply of advanced therapies that utilize our POCare platform and Orgenesis Mobile Processing Units and Labs (OMPULs).

University of Maryland Center for Environmental Science 16th annual Chesapeake Bay Watershed Report Card Press Event

Retrieved on: 
Wednesday, June 1, 2022
Integration and Application Network, Social Indicators Research, Comparative election campaign communication research, Income, Natural Resources, Environment, University, IAN, UMCES, Laboratory, Farm, Binary relation, Health, University of Maryland Center for Environmental Science, Water, Water quality, Environmental science, Housing, Agriculture, Forestry, Pharmaceutical industry, Watershed

WHAT: The University of Maryland Center for Environmental Science (UMCES) willpresent the 16th annual Chesapeake BayWatershedReport Card and report on the current state of the Bay and its Watershed on Monday, June 6, 2022 at 3 p.m.

Key Points: 
  • WHAT: The University of Maryland Center for Environmental Science (UMCES) willpresent the 16th annual Chesapeake BayWatershedReport Card and report on the current state of the Bay and its Watershed on Monday, June 6, 2022 at 3 p.m.
  • The report card provides ecosystem health status for key indicators of water quality and habitat, as well as economic and social.
  • UMCES not only creates the report card, with innovative, science-based metrics, but also outlines plans to involve both the public and private stakeholders in efforts to improve the Bay.
  • Please RSVP to Mike Smith, Yes& PR Agency Rep. for University of Maryland Center for Environmental Science: [email protected]
    ABOUT: The University of Maryland Center for Environmental Science leads the way toward better management of Marylands natural resources and the protection and restoration of the Chesapeake Bay.

Perdue Associates Join Oyster Recovery Partnership to Build Oyster Cages in Support of Bay Watershed Restoration

Retrieved on: 
Thursday, June 2, 2022
USDA, Poultry, Perdue Farms, Agriculture, Food, Natural Resources, Partnership, Environment, Government, Bay, Organization, Multimedia, Maryland Department of Natural Resources Police, University, Growth, Farmer, Livestock, Agribusiness, Health, Quality of life, ORP, Niman Ranch, University of Maryland Center for Environmental Science, Water quality, Environmental science, Aquaculture, Oyster, Perdue

SALISBURY, Md., June 2, 2022 /PRNewswire/ --As part of a commitment to environmental stewardship, Perdue Farms associates recently joined Oyster Recovery Partnership (ORP) representatives to build oyster cages to support the Marylanders Grow Oysters program to improve the health of the Chesapeake Bay watershed.

Key Points: 
  • SALISBURY, Md., June 2, 2022 /PRNewswire/ --As part of a commitment to environmental stewardship, Perdue Farms associates recently joined Oyster Recovery Partnership (ORP) representatives to build oyster cages to support the Marylanders Grow Oysters program to improve the health of the Chesapeake Bay watershed.
  • The cages are used to support the growth of young oysters during their most vulnerable first year of life.
  • "The work of Perdue associates will have a direct and meaningful impact on oyster restoration and improve water quality."
  • The Oyster Recovery Partnership has a 20-year-history of bringing together state and federal government agencies, scientists, watermen, and conservation organizations with the common goal of oyster restoration.

TDX INTERNATIONAL ANNOUNCES BIONIC INITIATIVE TO COMBAT MISINFORMATION AND DISINFORMATION

Retrieved on: 
Monday, April 11, 2022
Organizational structure of the United States Department of Defense, University of Maryland Center for Environmental Science, Bowie State University, HBCU, BSU, National, Growth, Multimedia, Innovation, Small Business Administration, Research, Faculty, Program, General manager, Alaska Native corporation, National security, Alaska Natives, Leadership, Independent test organization, View, Small business, College of Arts and Sciences, Government, Artificial intelligence, Industry, LLC, National Innovation Center, Historically black colleges and universities, Student, Economic development, Science, Department, R, University system, Research and development, Black, University System of Maryland, Renewable energy, Management, Public relations, Hawai

OAHU, Hawaii, April 11, 2022 /PRNewswire/ -- TDX International, LLC (TDXi), an Alaska Native Corporation based on Oahu, Hawaii, announces the establishment of a new National Innovation Center initiative with The Maryland Center at Bowie State University, a Historically Black College and University (HBCU), to perform Research & Development (R&D) projects aimed at countering misinformation and disinformation and associated negative consequences.

Key Points: 
  • The goal of the BIONIC initiative is to leverage research in Artificial Intelligence, Publicly Available Information, and cognitive/human behavioral sciences to combat adverse misinformation campaigns.
  • Ken Spedden, General Manager for TDXi stated:
    It is a blessing and honor to have co-created the BIONIC initiative in collaboration with our strategic partners.
  • The BIONIC initiative propels Bowie State University to the front lines of new research and development in this critical area of national need.
  • About TDX International Corporation: TDX International, LLC (TDXi), is a Small Business Administration certified Alaska Native small business subsidiary of TDX Corporation located on Oahu, Hawaii and headquartered in Anchorage, Alaska.

Orgenesis Reports Revenue Growth of 364% for 2021 and Provides Business Update

Retrieved on: 
Wednesday, March 30, 2022
An Act to exempt a particular class of securities from the Securities and Exchange Act, Therapy, Good manufacturing practice, Research, Hospital, CEO, Tel Aviv Sourasky Medical Center, Technology, TILS, Securities Act of 1933, GLOBE, Fausto Pocar, GMP, Annual report, Security (finance), University of Maryland Center for Environmental Science, Pain, Â, Pancreatectomy, Quality of life, Cell, Cyprus Securities and Exchange Commission, Stem cell, JV, NASDAQ, CGT, Survival, Telephone, Microsoft, Diabetes, RISK, Drug Quality and Security Act, Patient, Company, Protest and strikes of the CGT union 2021, Compliance, Johns Hopkins, COVID-19, Traction, Pharmaceutical industry, Online gambling, Labs, EU

(NASDAQ: ORGS) (Orgenesis or the Company), a global biotech company working to unlock the full potential of cell and gene therapies, today reports its financial results for the year ended December 31, 2021 and provides a business update.

Key Points: 
  • (NASDAQ: ORGS) (Orgenesis or the Company), a global biotech company working to unlock the full potential of cell and gene therapies, today reports its financial results for the year ended December 31, 2021 and provides a business update.
  • Vered Caplan, CEO of Orgenesis, said, Orgenesis revenues have increased more than four-fold to $35.5 million for 2021 compared to $7.7 million for 2020.
  • These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that are difficult to predict.
  • We undertake no obligation to revise or update any forward-looking statement for any reason.